Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyrimidines >  Urine (urea) pyrimidine >  5,6-Diamino-1-methyluracil

5,6-Diamino-1-methyluracil

Basic information Safety Supplier Related

5,6-Diamino-1-methyluracil Basic information

Product Name:
5,6-Diamino-1-methyluracil
Synonyms:
  • 2,4(1H,3H)-Pyrimidinedione,5,6-diamino-1-methyl-
  • 5,6-DIAMINO-1-METHYLURACIL
  • 5,6-diamino-1-methyl-pyrimidine-2,4-dione
  • 5,6-diamino-1-methylpyrimidine-2,4-dione
  • 5,6-diamino-1-methyl-pyrimidine-2,4-quinone
  • 5,6-Diamino-1-methyluracil ,97%
  • 5,6-Diamino-1-methylpyrimidine-2,4(1H,3H)-dione
  • 5,6-diaMino-1-Methyl-1,2,3,4-tetrahydropyriMidine-2,4-dione
CAS:
6972-82-3
MF:
C5H8N4O2
MW:
156.14
Mol File:
6972-82-3.mol
More
Less

5,6-Diamino-1-methyluracil Chemical Properties

Melting point:
270°C(lit.)
Density 
1.407±0.06 g/cm3(Predicted)
storage temp. 
Keep in dark place,Inert atmosphere,Room temperature
solubility 
DMSO (Sparingly), Methanol (Slightly), Water (Sparingly)
form 
powder to crystal
pka
9.18±0.40(Predicted)
color 
White to Light yellow to Green
CAS DataBase Reference
6972-82-3(CAS DataBase Reference)
More
Less

Safety Information

Hazard Codes 
F
Risk Statements 
36/37/38-10
Safety Statements 
26-36/37/39-16
HazardClass 
IRRITANT
HS Code 
29335990
More
Less

5,6-Diamino-1-methyluracil Usage And Synthesis

Chemical Properties

Yellow solid

Uses

6-Diamino-1-methyluracil is used to prepare tyrosine kinase erythropoietin inhibitors producing hepatocellular carcinoma receptor B4 (EphB4).

Synthesis

6972-78-7

6972-82-3

The general steps for the synthesis of 5,6-diamino-1-methyluracil from 6-amino-1-methyl-5-nitrosouracil are as follows: in order to improve the conversion of the reaction, the catalytic reduction reaction system of 6-amino-5-nitroso-1-methyluracil was optimized, and the post-treatment steps were adapted to obtain a high separation yield. The specific optimization steps were as follows: 1) 0.4 g of ammonium metatungstate-modified palladium metal catalyst (see Example 1 for preparation) was added to 80 ml of isopropanol with 10.0 g of 6-amino-5-nitroso-1-methyluracil substrate, and placed in a hydrogenation reactor with stirring; 2) the air in the hydrogenation reactor was displaced with nitrogen three times, and the temperature of the reactor was adjusted to 55° C. The reaction was carried out under a hydrogen pressure of 0.3 MPa The reaction was carried out under 0.3 MPa hydrogen pressure. After 2 hours of reaction, the reaction was analyzed by HPLC (99.6% conversion and 98.3% selectivity), the stirring was stopped, the hydrogen pressure was released, and the reactor was cooled down to room temperature. 3) The reaction solution was filtered to remove the catalyst, and the filtrate was collected and heated up to 50-60°C. 4) Pure water was slowly added dropwise to the hot filtrate until it appeared turbid, then the dropwise addition was paused and the solution was left for 2 hours. Continue adding water dropwise until no more crystals were precipitated (a total of 45 ml of water was added dropwise, of which 10 ml was added at the time of initial turbidity and 35 ml was added dropwise), the mixture was cooled down to 10 ℃, filtered and dried, to obtain a light yellow 5,6-diamino-1-methyluracil (92.3% yield by weight, 99.4% purity by volume).

References

[1] Russian Journal of Applied Chemistry, 1994, vol. 67, # 8.2, p. 1223 - 1224
[2] Zhurnal Prikladnoi Khimii (Sankt-Peterburg, Russian Federation), 1994, vol. 67, # 8, p. 1389 - 1391
[3] Chemical and Pharmaceutical Bulletin, 2013, vol. 61, # 4, p. 477 - 482
[4] Patent: CN107987028, 2018, A. Location in patent: Paragraph 0022
[5] Patent: CN104211702, 2018, B. Location in patent: Paragraph 0173; 0178; 0179

5,6-Diamino-1-methyluracil Preparation Products And Raw materials

Raw materials

5,6-Diamino-1-methyluracilSupplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Meryer (Shanghai) Chemical Technology Co., Ltd.
Tel
4006356688 18621169109
Email
market03@meryer.com
TCI (Shanghai) Development Co., Ltd.
Tel
021-67121386
Email
Sales-CN@TCIchemicals.com
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Email
2355560935@qq.com
Nanjing Habo Medical Technology Co., Ltd.
Tel
025-85760892 13376080562
Email
sales@habotech.com